Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by IMVARIA Inc.
IMVARIA Announces Strategic Investments from Leading Healthcare Companies
January 07, 2026
From
IMVARIA Inc.
Via
Business Wire
IMVARIA’s AI-Powered, Non-Invasive Bronchosolve Solution Meets Primary Endpoints for Lung Cancer Diagnosis in Pivotal VIRTUAL-BRONCH Study
October 20, 2025
From
IMVARIA Inc.
Via
Business Wire
IMVARIA Awarded Phase I NIH SBIR Grant to Extend the Company’s AI-powered Adjunctive Diagnostic Service into Oncology
September 03, 2025
From
IMVARIA Inc.
Via
Business Wire
IMVARIA Reports Multi-Site Clinical Experience With FDA-Authorized AI Diagnostic Service for Idiopathic Pulmonary Fibrosis at ATS 2025
May 18, 2025
From
IMVARIA Inc.
Via
Business Wire
IMVARIA Receives 510(k) Clearance for ScreenDx, a First-of-its-Kind Screening Algorithm to Assess for Interstitial Lung Disease
January 13, 2025
From
IMVARIA Inc.
Via
Business Wire
IMVARIA Announces FDA De Novo Marketing Authorization of Fibresolve, an AI Biomarker in Lung Fibrosis, and the Adoption of Novel CPT Billing Codes by the American Medical Association
January 16, 2024
From
IMVARIA Inc.
Via
Business Wire
IMVARIA Enters into Know-how Agreement with Mayo Clinic to Improve the Understanding of Cancer through AI Digital Biomarkers
November 01, 2023
From
IMVARIA Inc.
Via
Business Wire
IMVARIA Announces Data Demonstrating Company’s Non-Invasive Digital Biomarker for Predicting Mortality in Interstitial Lung Diseases
May 18, 2023
From
IMVARIA Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.